Zoya Alteber
Vice President Preclinical Development Edity Therapeutics
Seminars
Thursday 26th February 2026
Translating Precision Protein Delivery into the Clinic: Designing Trials for ED007’s Novel Immune-Activating Platform
10:15 am
- Present translational data supporting ED007’s CAR-guided delivery of proinflammatory immune sensor proteins into cancer cells
- Discuss how AI-engineered proteins convert tumours into inflammation hubs to engage both innate and adaptive immunity
- Outline clinical trial design strategies to evaluate safety, efficacy, and immune activation in solid tumours resistant to checkpoint inhibitors
